CTDDR

S.No.	Speaker's Name	Title of the Lecture
1	Prof. Hans-Joachim Knölker, Germany	Biomolecular Chemistry Directed Towards Drug Development
2	Prof. Domenico Spinelli, Italy	Fighting Against Tumours
3	Prof. Athina Geronikaki, Greece	Novel thiazolyl thiazolydin-4-one derivatives as HIV-1 reverse transcriptase inhibitors. Potential novel drugs for the treatment of AIDS.
4	Prof. Hiroshi Chuman, Japan	Novel Quantitative Structure-Activity Analyses of Protein Inhibitors Using Full Ab Initio Molecular Orbital Calculations on Their Complex Structures with Protein
5	Prof. R.R. Schmidt, Germany	Lipoteichoic Acids of Gram-positive Bacteria - Synthesis and Some Biological Properties
6	Dr. Ferenc Darvas, Hungary	Progress in nanomedicine: recent results on nanonization and nano-QSAR of drugs
7	Prof. Henk Timmerman, The Netherlands	Medicinal Chemistry, an ever evolving discipline
8	Prof. Lakshmi P. Kotra, Canada	De novo approaches to modulate protein-protein interactions in pursuit of drugs
9	Prof. Douglas W. Oliver, South Africa	Appraisal of ozone as biologically active molecule and experimental tool in biomedical sciences
10	Prof. H. Laatsch, Germany	Metabolites – Insights into Microbial Defence Systems
11	Prof. Cirrincione Girolamo, Italy	Pyrrolo-quinolinones with potent photochemiotherapeutic activity without DNA damage
12	Prof. Maurizio Botta, Italy	The fight against AIDS. The “old” Reverse Transcriptase (RT) and the “New” DDX3’
13	Prof. Marica Orioli, Italy	Cytotoxic reactive carbonyl species (RCS): From metabolic studies to the discovery of novel RCS sequestering agents
14	Prof. Johann Gasteiger, Germany	Modeling Chemical Reactions in Drug Design and Chemical Risk Assessment
15	Prof. David J Triggle, USA	Where is Biologically Useful Space In The Chemical Universe?
16	Prof. G.M. Halpern, USA	The Case for Pleasure
17	Dr. Marjan Vracko, Slovenia	QSAR in Drug research and in Regulatory Processes
18	Prof. Prabhat Arya, Hyderabad	Natural Product-Inspired Small Molecules as Modulators of Cell Death Pathways Involving Bcl-2 Family
19	Prof. Dr. Thomas Hohlfeld, Germany	Drug interactions at the level of platelet cyclooxygenase
20	Prof. Gilbert Kirsch, France	Awaited
21	Prof. Dr. Esin Aki-Sener, Turkey	DNA-Topoisomerase inhibitory activity of some heterocyclic compounds and their structure-activity relationships
22	Prof. Dr. Ismail Yalcin, Turkey	Antimicrobial activity and structure-activity relationships of some synthesized benzazoles and their possible metabolites
23	Dr. Solomon Nwaka, Switzerland	Awaited
24	Prof. Wafaa M. Abdou, Egypt	An Efficient Practical Synthesis of Thio-Bisphosphonic Acids for the Treatment of Arthritis, Based on the Chemistry of Disufides
25	Prof.Sultan T. Abu-Orabi, Jordan	Synthesis and Study of Heterocyclic Compounds: Triazoles
26	Dr. Ian Ahnfelt-Ronne, Denmark	Classical and novel biologics targeting chronic inflammation
27	Dr. György Dormán, Hungary	Towards accelerated anti-cancer drug discovery: integration of chemo-informatics, cell-based screening and grid computing.
28	Dr. Simeon Arseniyadis, France	Domino and Chiral Pool Approaches for Biologically Active Natural Product Synthesis : Towards New Pharmacophores
29	Dr. David Chen, Singapore	Bioactive Natural Products: Nature’s Gift to Science
30	Prof. Anjan Kowluru, USA	Protein lipidation Inhibitors as tools to study cellular function: Lessons learnt from the pancreatic beta-cell
31	Prof. Renu A. Kowluru, USA	Diabetic retinopathy and potential therapeutic
32	Dr. Laxminarayan Bhat, USA	A Practical Approach for Developing of Next Generation Safe and Effective Drugs
33	Prof. Dong-Pyo Kim, S. Korea	Novel Polymeric Microreactors for Bio & Chemical Synthetic Applications
34	Prof. Bakthan Singaram, USA	Sweetness and Light: Continuous glucose sensing and real time enzyme assays using boronic acid appended viologens
35	Dr. M.D. Nair, Bangalore	Nature - A Valuable Platform For New Drug Discovery
36	Prof. K. Muniyappa, Bangalore	Telomere Length Maintenance as a Target For Anticancer Drug Discovery
37	Prof. Eleanor Fish, Canada	Rational design and development of a broad spectrum antiviral drug: an interferon mimetic
38	Prof. A. Surolia, New Delhi	15-Deoxyspergualin Primarily Targets the Trafficking of Apicoplast Proteins in Plasmodium falciparum
39	Prof. George Varvounis, Greece	Synthesis and/or Reactivity of Novel Pyrrole, Indole, 1,2-Benzisoxazole, Phthalazine, Xanthone and Naphthalen-2(1H)-one Derivatives of Potential Pharmacological Interest
40	Prof. M.P. Kaushik, Gwalior	Gomphostenin and Gomphocritine: New Antimalarial Compounds from the Natural Source
41	Prof. Dr. U. Beifuss, Germany	Copper-catalyzed reactions for the synthesis of biologically active heterocycles
42	Prof. Thirumala Govender, South Africa	Exploring the potential of buccal drug delivery systems for enhanced drug therapy
43	Prof. Bernd Rosenkranz, South Africa	Biomarkers as Surrogate Endpoints in Clinical Trials
44	Prof. Vladimir Poroikov, Russia	Computer-assisted prediction and design of multitargeted drugs
45	Prof. Richard K. Haynes, Hong Kong	'From Methylene Blue to Chloroquine to the Modern Artemisinin Antimalarial Artemisone: Development, and Clinical Aspects'
46	Prof. Sarel F. Malan, South Africa	Polycyclic cage structures as lipophilic scaffolds for neuroprotective drugs
47	Prof. Brian Wigdahl, USA	Targeting the HIV-1 transcription complex: A clinical and translational enterprise
48	Prof. H. Ila, India	Design and Developement of New Synthetic Methods for Biologically Important heterocyclic Cores
49	Prof. Sandeep Verma, India	Iron Nanomineralization in an Aged Blood Protein: Implications in Disease Biology
50	Dr. Absar Ahmad, India	Biotechnology of Endophytic Fungi: Inorganic Nanomaterials and Drugs
51	Prof. V.S. Parmar, India	Development of natural products based antimicrobial, anti-inflammatory and antiplatelet agents
52	Prof. P. Rama Rao, India	Transitional Research –Drug Discovery and Development
53	Prof. Anil Gulati, USA	Recent advances in endothelin based drug therapies
54	Prof. Y.K. Gupta, India	Herbal drugs in epilepsy and alzheimer’s disease